Bentley Pharmaceuticals

As of July 22, 2008, Bentley Pharmaceuticals, Inc. was acquired by Teva Pharmaceutical Industries Limited. Bentley Pharmaceuticals, Inc. is engaged in the research, development, licensing, and commercialization of generic and branded pharmaceutical products, active pharmaceutical ingredients, and drug delivery technologies through its subsidiaries. It provides pharmaceutical treatments for cardiovascular, gastrointestinal, infectious diseases, and central nervous system disorders in Europe. The company was founded in 1974 and is headquartered in Exeter, New Hampshire.